So excited our paper on mitochondrial phosphatidylinositol (PI) is finally out and chosen as an Editor’s Highlight in @NatureComms! PI is a known component of mitochondrial membranes, yet how its levels within mitochondria shape core functions, is unknown.
https://t.co/DdsxQYRDns
Neutralizing interleukin-10 autoantibodies were found in a subgroup of patients with inflammatory bowel disease and in no controls without IBD. Seropositivity was strongly associated with the IBD HLA-DRB1*01:03 risk allele. Full study results: https://t.co/C5oIChPFbG
Science behind the Study: Autoantibodies against Cytokines — From Infection to Inflammation https://t.co/Ja8nORGjYr
Paul Bastard, MD, PhD, and Jean-Laurent Casanova, MD, PhD, describe the scientific foundations of a study implicating autoantibodies against interleukin-10 in persons with inflammatory bowel disease.
Read the editorial “Autoantibodies against Cytokines — From Infection to Inflammation”: https://t.co/Ja8nORGjYr
p16High senescence-associated immune cells promote disease tolerance and healthy aging via TLR7 and STING control of adenosine concentrations @ImmunityCP
https://t.co/eWiEGS2GR3
https://t.co/paPRCMZY94
Chimeric MHC class I and II-restricted non-self epitopes broaden anti-tumor T cell reactions. From Rongsheng Zhang, Tasuku Honjo, Kenji Chamoto and colleagues: https://t.co/4n8kiUXxWP
📘 Part of JEM #Cancer Collection: https://t.co/G4kZuFwhgu
#EACR2026
We present Effero-seq, a novel approach combining #scRNA-seq with lysosomal acidification tracking by using pHrodo - a pH-sensitive fluorescent marker. This method allowed us to track gradual changes in macrophage gene expression driven by efferocytosis of apoptotic cells (ACs).